Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: Insights into structural requirements for kininogen expression

Blood

Volumn 101, Issue 11, 2003, Pages 4430-4436

  Krijanovski, Yelena ^b   Proulle, Valerie ^b   Mahdi, Fakhri ^b   Dreyfus, Marie ^b   Müller Esterl, Werner ^b   Schmaier, Alvin H ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; HIGH MOLECULAR WEIGHT KININOGEN; KININOGEN; MONOCLONAL ANTIBODY; WARFARIN;

ANGIOGRAPHY; ANTICOAGULANT THERAPY; ANTIGEN DETECTION; ARTERY DISSECTION; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; CERVICAL SPINE INJURY; COMPUTER ASSISTED TOMOGRAPHY; EXON; FRAMESHIFT MUTATION; GENE MUTATION; HEADACHE; HUMAN; MALE; MOLECULAR WEIGHT; PARTIAL THROMBOPLASTIN TIME; PLASMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; THROMBOSIS; UNCONSCIOUSNESS; VERTEBRAL ARTERY; VISUAL IMPAIRMENT; VOMITING; BIOSYNTHESIS; BLOOD; CHILD; FAMILY HEALTH; GENETICS; IMMUNOBLOTTING; INTRON; PROTEIN TERTIARY STRUCTURE; SECRETION; STOP CODON;

CHILD; CODON, NONSENSE; EXONS; FAMILY HEALTH; FRAMESHIFT MUTATION; HUMANS; IMMUNOBLOTTING; INTRONS; KININOGEN, HIGH-MOLECULAR-WEIGHT; KININOGENS; MALE; PROTEIN STRUCTURE, TERTIARY; THROMBOSIS;

EID: 0038481236     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3329     Document Type: Article

References (36)

1. Colman RW, Bagdasarian A, Talamo RC, et al. Williams trait: human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975;56:1650-1662.
2. Cheung PP, Kunapuli SP, Scott CF, Wachtfogel YT, Colman RW. Genetic basis of total kininogen deficiency in Williams trait. J Biol Chem. 1993;268:23361-23365.
3. Schmaier AH, Zuckerberg A, Silverman C, Kuchibhotla J, Tuszynski GP, Colman RW. High-molecular weight kininogen: a secreted platelet protein. J Clin Invest. 1983;71:1477-1489.
4. Waldmann R, Rebuck JW, Saito H, Abraham JP, Caldwell J, Ratnoff OD. Fitzgerald factor: a hitherto unrecognized coagulation factor. Lancet. 1975;1:949-951.
5. Scicli AG, Mindroiu T, Scicli G, Carretero OA. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. J Lab Clin Med. 1982;100:81-93.
6. Schmaier AH. The plasma kallikrein/kinin system counterbalances the renin angiotensin system. J Clin Invest. 2002;109:1007-1009.
7. Meloni FJ, Schmaier AH. Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. J Biol Chem. 1991;266:6786-6794.
8. Salvesen G, Parkes C, Abrahamson M, Grubb A, Barrett AJ. Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and inhibitory activity for cysteine proteinases. Biochem J. 1986;234:429-434.
9. Jiang Y, Müller-Esterl W, Schmaier AH. Domain 3 of kininogen contains a cell binding site and a site that modifies thrombin activation of platelets. J Biol Chem. 1992;267:3712-3717.
10. Hasan AAK, Amenta S, Schmaier AH. Bradykinin and its metabolite, ARG-PRO-PRO-GLY-PHE, are selective inhibitors of α-thrombin-induced platelet activation. Circulation. 1996;94:517-528.
11. Kakizuka A, Ingi T, Mural T, Nakanishi S. A set of U1 snRNA-complementary sequences involved in governing alternative RNA splicing of the kininogen gene. J Biol Chem. 1990;265:10102-10108.
12. Meloni FJ, Gustafson EJ, Schmaier AH. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Blood. 1992;79:1233-1244.
13. Tait JF, Fujikawa K. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. J Biol Chem. 1987;262:11651-11656.
14. Motta G, Rojkjaer R, Hasan AAK, Cines DB, Schmaier AH. High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood. 1998;91:516-528.
15. Mahdi F, Shariat-Madar Z, Todd III RF, Figueroa C, Schmaier AH. Expression and co-localization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood. 2001;97:2342-2350.
16. Shariat-Madar Z, Mahdi F, Schmaier AH. Identification and characterization of prolylcaraboxypeptidase as an endothelial cell prekallikrein activator. J Biol Chem. 2002;277:17962-17969.
17. Moreira CR, Schmaier AH, Mahdi F, da Motta G, Nader HB, Shariat-Madar Z. Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator. FEBS Lett. 2002;523:167-170.
18. Oyda CE, Marinkovic DV, Hammon KJ, Stewart TA, Erdos EG. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J Biol Chem. 1978;253:5927-5931.
19. Zhao Y, Qiu Q, Mahdi F, Shariat-Madar Z, Rojkjaer R, Schmaier AH. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Am J Physiol Heart Circ Physiol. 2001;280:H1821-H1829.
20. Colman RW, Jameson BA, Lin Y, Johnson D, Mousa SA. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Blood. 2000;95:543-550.
21. Zhang J-C, Claffey K, Sakthivel R, et al. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5. FASEB J. 2000;14:2589-2600.
22. Kaufmann J, Haasemann M, Modrow S, Müller-Esterl W. Structural dissection of the multidomain kininogens: fine mapping of the target epitopes of antibodies interfering with their functional properties. J Biol Chem. 1993;268:9079-9081.
23. Hasan AAK, Cines DB, Herwald H, Schmaier AH, Müller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J Biol Chem. 1995;270:19256-19261.
24. DeLa Cadena R, Scott CF, Colman RW. Evaluation of a functional microassay for determination of plasma prekallikrein. J Lab Clin Med. 1987;109:601-607.
25. Schmaier AH, Farber A, Schein R, Sprung C. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. J Lab Clin Med. 1988;112:182-192.
26. Alhenc-Gelas M, Arnaud E, Nicaud V, et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost. 1999;81:506-510.
27. Yu H, Anderson PJ, Freedman BI, Rich SS, Bowden DW. Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics. 2000;69:225-234.
28. Scott CF, Colman RW. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. J Clin Invest. 1980;65:413-421.
29. Herwald H, Renne T, Meijers JCM, et al. Mapping of the discontinuous kininogen binding site of prekallikrein: a distal binding segment is located in the heavy chain of domain A4. J Biol Chem. 1996;271:13061-13067.
30. Renne T, Dedio J, Meijers JCM, Chung D, Müller-Esterl W. Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein: evidence for a critical role of apple domain-2. J Biol Chem. 1999;274:25777-25784.
31. Vogel R, Kaufmann J, Chung DW, Kellermann J, Müller-Esterl W. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries: mimicking of the predicted binding site by antiidiotype antibodies. J Biol Chem. 1990;265:12494-12502.
32. Schmaier AH, Schutsky D, Farber A, Silver LD, Bradford HN, Colman RW. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains. J Biol Chem. 1987;262:1405-1411.
33. Kakizuka A, Kitamura N, Nakanishi S. Localization of DNA sequences governing alternative mRNA production of rat kininogen genes. J Biol Chem. 1988;263:3884-3892.
34. Kakizuka A, Ingi T, Murai T, Nakanishi S. A set of U1 snRNA-complementary sequences involved in governing alternative RNA splicing of the kininogen gene. J Biol Chem. 1990;265:10102-10108.
35. Hayashi H, Ishimaru F, Fujita T, Tsurumi N, Tsuda T, Kimura I. Molecular genetic survey of five Japanese families with high-molecular-weight kininogen deficiency. Blood. 1990;75:1296-1304.
36. Lin Y, Harris RB, Yan W, McCrae KR, Zhang H, Colman RW. High molecular weight kininogen peptides inhibit the formation of kallikrein on endothelial cell surfaces and subsequent urokinase-dependent plasmin formation. Blood. 1997;90:690-697.